Stephen Machatha - Net Worth and Insider Trading
Stephen Machatha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen Machatha owns 1 companies in total, including Aldeyra Therapeutics Inc (ALDX) .
Click here to see the complete history of Stephen Machatha’s form 4 insider trades.
Insider Ownership Summary of Stephen Machatha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2020-12-08 | Chief Development Officer |
Stephen Machatha Trading Performance
Stephen Machatha Ownership Network
Ownership Network List of Stephen Machatha
Ownership Network Relation of Stephen Machatha
Stephen Machatha Owned Company Details
What does Aldeyra Therapeutics Inc do?
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
Who are the key executives at Aldeyra Therapeutics Inc?
Stephen Machatha is the Chief Development Officer of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include See Remarks Bruce Greenberg , 10 percent owner Joseph Edelman , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, Stephen Machatha made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net purchase of 1,305,206 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 17,700 shares made by Todd C Brady , and a net purchase of 4,323 shares made by Martin Joseph Joyce .
In summary, during the past 3 months, insiders sold 0 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 1,327,229 shares were bought by its insiders, resulting in a net purchase of 1,327,229 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
Stephen Machatha Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen Machatha. You might contact Stephen Machatha via mailing address: 131 Hartwell Avenue, Suite 320, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
